• BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Recommendation of "Moderate Buy" by Brokerages

    Источник: Buzz FX / 25 фев 2025 02:51:17   America/New_York


    BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat February 25, 2025 Share Link copied to clipboard. BridgeBio Pharma, Inc. ( NASDAQ:BBIO - Get Free Report ) has receive
    Read more...
Опубликовать